Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Eisai Gives Takeover-Blocking Authority To Outside Directors

This article was originally published in PharmAsia News

Executive Summary

Eisai has established a committee of outside directors to be ready to take protective action if the company becomes a takeover target by another company. The directors themselves proposed the program and have been given the charge to decide for themselves whether to implement it. Normally, company executives make an anti-takeover effort, but they have been criticized for protecting their own interests instead of that of the company. More than half of Eisai's board members are outside directors given independence to act so the decision would not be left to people close to the founding family or officials with major business connections. (Click here for more - a subscription may be required

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069177

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel